| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a leading pharmaceutical ..
>Volltext.. |
| 874207.75 Mio. EUR |
| 901900.92 Mio. EUR |
| 51343.92 Mio. EUR |
| 24442.27 Mio. EUR |
| 15909.67 Mio. EUR |
| 17.5 EUR |
| 36729.43 Mio. EUR |
| 8461.06 Mio. EUR |
| 13879.15 Mio. EUR |
| 0.25 |
| 37.97% |
| 108.73% |
| 5.15 EUR |
| 0.54% |
| 0.56% |
| 14.11.25 - 1.2880499€ 15.08.25 - 1.287€ >weitere anzeigen... |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.115.696.921 USD. |
| ELI LILLY, LILLY DEUTSCHLAND |
| 27.11.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|